(4th Dec-8 dec 2017)
ASIAN HARMONIZATION WORKING PARTY Workshop (4 th Dec-8 th dec 2017) Venue: The grand hotel, Nelson Mandela Road, Vasant Kunj - Phase II, New Delhi-110070 Day 1 (4thDecember, 2017) Time (hrs) TOPIC NAME & DESIGNATION
Download (4th Dec-8 dec 2017)
Information
Domain:
Source:
Link to this page:
Documents from same domain
SCHEDULE M - Central Drugs Standard Control …
www.cdsco.nic.in[SCHEDULE M] [See Rules 71, 74, 76 and 78] GOOD MANUFACTURING PRACTICES AND REQUIREMENTS OF PREMISES, PLANT AND EQUIPMENT FOR PHARMACEUTICAL PRODUCTS. Note: - To achieve the objectives listed below, each licensee shall evolve appropriate
GUIDANCE FOR INDUSTRY ON PREPARATION OF …
www.cdsco.nic.inguidelines on common technical document (ctd) 28.10.2010 page 1 of 110 guidance for industry on preparation of common technical document for import / manufacture and marketing approval
Ministry of Health and Family Welfare, …
www.cdsco.nic.in1 Ministry of Health and Family Welfare, Government of India has approved 25 panels of experts of various therapeutic areas. For evaluation of various categories of applications of clinical trials, new
CDSCO - Guidance for Industry
www.cdsco.nic.inGuidance for Industry Central Drugs Standard Control Organization Page 3 OBJECTIVE This Guidance has been developed in conformity with Drugs and Cosmetics
No.DCG (I/Misc./2017 (68) Directorate General of …
www.cdsco.nic.inPage 1 of 1 No.DCG (I/Misc./2017 (68) Central Drugs Standard Control Organisation Directorate General of Health Services Office of Drugs Controller General India
Central Drugs Standard Control Organization
www.cdsco.nic.inCentral Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India
Guidelines on Similar Biologic: Regulatory …
www.cdsco.nic.inGuidelines on Similar Biologic: Regulatory Requirements for Marketing Authorization in India
FIXED DOSE COMBINATIONS APPROVED BY DCG …
www.cdsco.nic.inFIXED DOSE COMBINATIONS APPROVED BY DCG (I) SINCE 1961 TILL NOVEMBER, 2014 # Name of Drug Indication Date of approval …
DRAFT GUIDANCE ON APPROVAL OF CLINICAL …
www.cdsco.nic.inguidelines on approval of clinical trial & new drugs effective date: page 1 of 71 draft guidance on approval of clinical trials & new drugs draft guidance
CENTRAL DRUGS STANDARD CONTROL …
www.cdsco.nic.incentral drugs standard control organisation directorate general of health services, ministry of health and family welfare government of india
Related documents
2016–17 - Home - South East Water
southeastwater.com.auSouth East Water Annual Report 2016–17 01 Report of operations Overview of South East Water’s functions and services 3 A message from the Chair and Managing Director 4
WHAT YOU SHOULD KNOW ABOUT TORDON HERBICIDES
www.arborchem.comWHAT YOU SHOULD KNOW ABOUT TORDON HERBICIDES Vegetation managers and foresters use Tordon* herbicides to control unwanted weeds, brush and trees beneath electrical powerlines,
Guidelines for School Playgrounds
www.education.vic.gov.au6 medical care as the result of playground injury. Many of these injuries are predictable and preventable. Falls from play equipment are the leading cause of injury in …
HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA …
www.ehrn.co.zaExamination guidelines restoration applications – environmental health practitioners. Revision 03. - 3 - The focus of the oral assessment is however not to verify the candidates’
Unique Device Identification (UDI) - GMTA Global Medical ...
www.globalmedicaltechnologyalliance.org2 EXECUTIVE SUMMARY The implementation of a globally harmonized unique device identification (UDI) system will positively impact many aspects of the medical device and healthcare
A guide to health and safety regulation in Great Britain HSE49
www.hse.gov.ukA guide to health and safety regulation in Great Britain Page 3 of 26 Health and Safety Executive This guide outlines the occupational health and safety system in Great Britain (GB).
Risk-based Monitoring Strategies for Improved Clinical ...
www.cognizant.comRisk-based Monitoring Strategies for Improved . Clinical Trial Performance. To address draft regulatory guidance for risk-based . clinical trial monitoring, sponsors should consider